Content area
Full Text
We read, with much astonishment, the article by Wise claiming that "selling" scientific advice procedures enables institutional capture by drug companies. 1 The National Institute for Health and Care Excellence (NICE) strongly supports the development of processes for the provision of parallel scientific advice between the European Medicines Agency and Health Technology Assessment (HTA) bodies to the developers of medicinal products.
The provision of scientific advice to drug companies does not threaten the independence of bodies such as NICE. By implying that scientific advice is "unnecessary if scientific data...